Search results for "Online Only"

showing 7 items of 17 documents

Cryptic Insertions Of The Immunoglobulin Light Chain Enhancer Region Near CCND1 In T(11;14)-Negative Mantle Cell Lymphoma

2019

Cyclin D1+ mantle cell lymphoma (MCL) is molecularly characterized by the t(11;14)(q13;q32) or rearrangements of CCND1 gene with the immunoglobulin (IG) light chains.1,2 Most MCL can be diagnosed based on the characteristic pathologic features and cyclin D1 expression without the need for demonstrating the genetic translocation. However, in cases with atypical morphologic or phenotypic features other B-cell neoplasms that sometimes also have cyclin D1 positivity may be in the differential diagnosis.1 In these situations the detection of the CCND1 rearrangements may assist in the diagnosis since most other lymphomas do not carry translocations of the gene.3-7 A subset of plasma cell myelomas…

MaleLimfomesHematologyLymphoma Mantle-CellMiddle AgedTranslocation GeneticMalaltia de Hodgkin03 medical and health sciencesMutagenesis Insertional0302 clinical medicinePolitical sciencehemic and lymphatic diseasesHumansCyclin D1Immunoglobulin Light ChainsLymphomasHodgkin's diseaseOnline Only ArticlesImmunoglobulinesHumanities030215 immunologyAged
researchProduct

Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs

2019

It is well established that immune thrombocytopenia (ITP) results from increased immune mediated platelet destruction (anti-platelets antibodies, autoreactive T cells, and reduction of regulatory T cells) along with impaired production in the bone marrow.1 The latter has been attributed to both cellular and humoral mediators that cause suppression of megakaryocyte production and maturation.2 Current standard first line therapy consists of corticosteroids, with or without intravenous Ig, achieving about 70-80% response rate. However, a consistent proportion of patients would relapse after corticosteroid discontinuation or tapering, and requires further therapy. ...

MaleOncologymedicine.medical_specialtyRecombinant Fusion ProteinsEltrombopagBone Marrow CellsImmune Thrombocytopenic PurpuraReceptors FcBenzoateschemistry.chemical_compoundInternal medicinemedicineHumansOnline Only ArticlesThrombopoietinRetrospective StudiesPurpura Thrombocytopenic IdiopathicRomiplostimbusiness.industryRetrospective cohort studyromiplostimHematologyMiddle AgedImmune thrombocytopeniaClinical trialHydrazinesmedicine.anatomical_structureThrombopoietinchemistryCohortPyrazolesFemaleBone marroweltrombopagbusinessFollow-Up Studiesmedicine.drugHaematologica
researchProduct

Effectiveness of a Psychosocial Care Quality Improvement Strategy to Address Quality of Life in Patients with Cancer: The HuCare2 Stepped-Wedge Clust…

2021

Key Points Question Does an implementation strategy integrating psychosocial care into cancer centers improve at least 1 of 2 domains (emotional or social function) of health-related quality of life? Findings This stepped-wedge cluster randomized clinical trial included 762 patients with cancer at high risk for reduced quality of life. Health-related quality of life score improved from baseline to 3 months among participants in the Humanization in Cancer Care Quality Improvement Strategy arm vs the usual care arm, showing a statistically significant difference for emotional function, but not for social function. Meaning This study suggests the use of an implementation strategy aiming to pro…

Malemedicine.medical_specialtyQuality managementPsychological interventionPsychiatric Rehabilitationlaw.inventionQuality of life (healthcare)Randomized controlled triallawNeoplasmsMedicineCluster AnalysisHumansCluster randomised controlled trialOriginal InvestigationAgedbusiness.industryResearchCancer Care FacilitiesGeneral MedicineOdds ratioMiddle AgedQuality ImprovementAged; Cluster Analysis; Cross-Sectional Studies; Female; Humans; Italy; Male; Middle Aged; Neoplasms; Psychiatric Rehabilitation; Quality of Life; Quality ImprovementOnline OnlyCross-Sectional StudiesOncologyItalyPhysical therapyQuality of LifeFemalebusinessPsychosocial
researchProduct

Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis

2019

Oncologymedicine.medical_specialtySalvage therapyDrug resistanceLymphoma Mantle-Cellchemistry.chemical_compoundText miningPiperidinesInternal medicinemedicineHumansOnline Only ArticlesSurvival rateSalvage TherapyClinical Trials as Topicbusiness.industryAdenineHematologymedicine.diseasePrognosisLymphomaSurvival RatePyrimidineschemistryDrug Resistance NeoplasmIbrutinibRelapsed refractoryPyrazolesMantle cell lymphomaNeoplasm Recurrence LocalbusinessFollow-Up Studies
researchProduct

Association of Exposure to Ambient Air Pollution With Thyroid Function During Pregnancy

2019

Key Points Question Is exposure to ambient air pollution in the first trimester associated with thyroid function throughout pregnancy? Findings Among 9931 pregnant women in 4 European cohorts and 1 US cohort, an increase of 5 μg/m3 in exposure to particulate matter with an aerodynamic diameter of 2.5 μm or less was associated with 20% higher odds of hypothyroxinemia. Meaning The findings of this study raise the possibility that exposure to particulate matter might disrupt thyroid function in pregnant women.

PhysiologyThyrotropin010501 environmental sciences01 natural sciencesCohort Studies0302 clinical medicinePregnancy030212 general & internal medicineOriginal Investigationbiologymedicine.diagnostic_testAmbient air pollutionThyroidGeneral Medicine3. Good healthOnline Onlymedicine.anatomical_structureHypothyroxinemiaCohortGeneration RFemaleThyroid functionEnvironmental HealthAdultendocrine systemNitrogen DioxideThyroid function testsIodide Peroxidase03 medical and health sciencesYoung AdultThyroid peroxidaseEnvironmental healthAir PollutionmedicineHumansParticle Size0105 earth and related environmental sciencesAutoantibodiesPregnancybusiness.industryResearchEnvironmental Exposuremedicine.diseaseThyroid DiseasesPregnancy Trimester FirstThyroxine13. Climate actionbiology.proteinParticulate MatterbusinessJAMA network open
researchProduct

Sparse relative risk regression models

2020

Summary Clinical studies where patients are routinely screened for many genomic features are becoming more routine. In principle, this holds the promise of being able to find genomic signatures for a particular disease. In particular, cancer survival is thought to be closely linked to the genomic constitution of the tumor. Discovering such signatures will be useful in the diagnosis of the patient, may be used for treatment decisions and, perhaps, even the development of new treatments. However, genomic data are typically noisy and high-dimensional, not rarely outstripping the number of patients included in the study. Regularized survival models have been proposed to deal with such scenarios…

Statistics and ProbabilityClustering high-dimensional dataComputer sciencedgLARSInferenceScale (descriptive set theory)BiostatisticsMachine learningcomputer.software_genreRisk Assessment01 natural sciencesRegularization (mathematics)Relative risk regression model010104 statistics & probability03 medical and health sciencesNeoplasmsCovariateHumansComputer Simulation0101 mathematicsOnline Only ArticlesSurvival analysis030304 developmental biology0303 health sciencesModels Statisticalbusiness.industryLeast-angle regressionRegression analysisGeneral MedicineSurvival AnalysisHigh-dimensional dataGene expression dataRegression AnalysisArtificial intelligenceStatistics Probability and UncertaintySettore SECS-S/01 - StatisticabusinessSparsitycomputerBiostatistics
researchProduct

Inhibition of TSH/IGF-1 Receptor Crosstalk by Teprotumumab as a Treatment Modality of Thyroid Eye Disease

2021

Abstract Context We previously presented evidence that TSH receptor (TSHR)-stimulating autoantibodies (TSAbs) bind to and activate TSHRs but do not bind to IGF1 receptors (IGF1Rs). Nevertheless, we showed that IGF1Rs were involved in thyroid eye disease (TED) pathogenesis because TSAbs activated crosstalk between TSHR and IGF1R. Teprotumumab, originally generated to inhibit IGF1 binding to IGF1R, was recently approved for the treatment of TED (Tepezza). Objective To investigate the role of TSHR/IGF1R crosstalk in teprotumumab treatment of TED. Design We used orbital fibroblasts from patients with TED (TEDOFs) and measured stimulated hyaluronan (HA) secretion as a measure of orbital fibrobla…

endocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismClinical BiochemistryThyrotropinStimulationContext (language use)Antibodies Monoclonal HumanizedBiochemistryReceptor IGF Type 1EndocrinologyInternal medicinemedicineHumansHyaluronic AcidOnline Only ArticlesReceptorFibroblastInsulin-like growth factor 1 receptorGene knockdownTeprotumumabChemistryBiochemistry (medical)Receptors Thyrotropineye diseasesGraves Ophthalmopathybody regionsCrosstalk (biology)Endocrinologymedicine.anatomical_structuremedicine.drugThe Journal of Clinical Endocrinology & Metabolism
researchProduct